Prestige Consumer Healthcare (PBH) reported $249.53 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.6%. EPS of $0.95 for the same period compares to $0.90 a year ago.
The reported revenue represents a surprise of -4.73% over the Zacks Consensus Estimate of $261.91 million. With the consensus EPS estimate being $1.01, the EPS surprise was -5.94%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Prestige Consumer Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- OTC Healthcare- International: $36.95 million compared to the $35.01 million average estimate based on three analysts. The reported number represents a change of +6.1% year over year.
- Revenues- OTC Healthcare- North American: $212.58 million versus the three-analyst average estimate of $225.14 million. The reported number represents a year-over-year change of -8.5%.
- Gross profit- OTC Healthcare- North American: $120.4 million versus the two-analyst average estimate of $125.39 million.
- Gross profit- OTC Healthcare- International: $19.93 million versus the two-analyst average estimate of $19.9 million.
View all Key Company Metrics for Prestige Consumer Healthcare here>>>
Shares of Prestige Consumer Healthcare have returned -4.7% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Prestige Consumer Healthcare Inc. (PBH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
